Visceral obesity and the risk of ischaemic heart disease: insights from the Québec Cardiovascular Study (Q34034922)

30 July 2017

1 reference

title

Visceral obesity and the risk of ischaemic heart disease: insights from the Québec Cardiovascular Study (English)

1 reference

arteriosclerotic heart disease

30 July 2017

0 references

1 reference

1 reference

Lamarche B

1

1 reference

30 July 2017

Lemieux S

series ordinal

2

1 reference

30 July 2017

Dagenais GR

series ordinal

3

1 reference

30 July 2017

Després JP

series ordinal

4

1 reference

30 July 2017

1 April 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

1 reference

30 July 2017

8 Suppl B

1 reference

30 July 2017

1-8

1 reference

Relation of body fat distribution to metabolic complications of obesity.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Central obesity and coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Splanchnic insulin metabolism in obesity. Influence of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Adiposity, fat distribution, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Cardiovascular risk factors and the prediabetic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

LDL size and subclass pattern in Mexico City residents and San Antonio Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

How good a marker is insulin level for insulin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Why can high insulin levels indicate a risk for coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Is insulin really a heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Serum insulin and incident coronary heart disease in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Beyond LDL cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Synthesis and secretion of apolipoprotein B from cultured liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Particle size: the key to the atherogenic lipoprotein?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

In defence of insulin: a critique of syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Why is insulin not a risk factor for coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Hyperinsulinemia and the Risk of Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Role of apolipoprotein levels in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

LDL particle size distribution. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980018-X

7 January 2021

10.1016/S1096-6374(98)80018-X

Identifiers

DOI

1 reference

30 July 2017

1 reference